QSI - NASDAQ

Quantum-Si incorporated

QSI·NASDAQ

$1.19

-4.0%

HealthcareBiotechnology

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$235.41M

EPS-0.5100

P/E Ratio-2.33

Earnings Date08/04/2026

245.61M

Assets

-1%

3Y-37.0%

5Y+505.0%

10Y+557.0%

25.38M

Total Liabilities

-22%

3Y-23.0%

5Y+464.0%

10Y+1217.0%

220.23M

Total Equity

3Y-39.0%

5Y+510.0%

10Y+521.0%

Quantum-Si incorporated Funding & Solvency Profile

QSI · NASDAQ

Current Assets

Cash & Cash Equivalents21.64M

Net Receivables561.00K

Inventory3.20M

Other Current Assets9.19M

Total Current Assets176 M

Non-Current Assets

Property, Plant & Equipment16.66M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets53.09M

Total Non-Current Assets70 M

Total Assets

245.61M

Financial Health Analysis

Current Ratio

7.64x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.12x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

153 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

72% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Quantum-Si incorporated Balance Sheet

QSI • NASDAQ

Quantum-Si incorporated Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	21.6M	49.2M	133.9M	84.3M	35.8M	36.9M	32.9M
Short-Term Investments	141.3M	160.4M	123.9M	267M	435.5M	0.0	0.0
Cash & Short-Term Investments	162.9M	209.6M	257.7M	351.3M	471.3M	36.9M	32.9M
Net Receivables	561K	1.3M	368K	0.0	0.0	0.0	0.0
Accounts Receivables	561K	1.3M	368K	0.0	0.0	0.0	0.0
Inventory	3.2M	4.1M	3.9M	0.0	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	5.9M	948K	110K
Other Current Assets	9.2M	3M	4.3M	6.9M	0.0	0.0	826K
Total Current Assets	175.9M	218M	266.3M	358.2M	477.2M	37.9M	33.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	16.7M	29.1M	30.7M	32.6M	15.9M	2M	2.6M
Goodwill	0.0	0.0	0.0	0.0	9.5M	0.0	0.0
Intangible Assets	0.0	0.0	532K	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	0.0	0.0	532K	0.0	9.5M	0.0	0.0
Other Non-Current Assets	53.1M	808K	695K	697K	690K	738K	994K
Total Non-Current Assets	69.7M	29.9M	31.9M	33.3M	26.1M	2.7M	3.5M
Total Assets	245.6M	247.9M	298.3M	391.5M	503.2M	40.6M	37.4M
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.6M	3.3M	1.8M	3.9M	3.4M	1.3M	869K
Accounts Payable	1.6M	1.9M	1.8M	3.9M	3.4M	1.3M	869K
Other Payables	0.0	1.3M	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	10.7M	8.1M	10.3M	4.6M	846K	951K
Short Term Debt	1.8M	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	3.7M	1.6M	1.4M	859K	0.0	0.0
Tax Payables	0.0	1.3M	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	19.6M	514K	194K	88K	2.7M	579K	107K
Total Current Liabilities	23M	18.2M	11.6M	15.7M	11.5M	2.8M	1.9M
NON-CURRENT LIABILITIES
Long Term Debt	2.3M	0.0	0.0	0.0	0.0	1.7M	0.0
Other Non-Current Liabilities	34K	5M	1.3M	996K	7.4M	0.0	0.0
Total Non-Current Liabilities	2.4M	14.3M	15M	17.1M	14.7M	1.7M	0.0
Capital Lease Obligations	0.0	12.9M	15.3M	17.4M	8.1M	0.0	0.0
Total Liabilities	25.4M	32.5M	26.6M	32.8M	26.2M	4.5M	1.9M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	195.8M	160.6M
Common Stock	22K	18K	14K	14K	14K	1K	1K
Additional Paid-In Capital	918.2M	812M	767.2M	758.4M	744.3M	12.5M	10.5M
Retained Earnings	-698M	-596.6M	-495.6M	-399.7M	-267.2M	-172.2M	-135.6M
Accumulated Other Comprehensive Income/Loss	-6K	45K	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	220.2M	215.4M	271.6M	358.7M	477M	36.1M	35.5M
Total Equity	220.2M	215.4M	271.6M	358.7M	477M	36.1M	35.5M
SUMMARY
Total Liabilities & Equity	245.6M	247.9M	298.3M	391.5M	503.2M	40.6M	37.4M
Total Investments	141.3M	160.4M	123.9M	267M	435.5M	0.0	0.0
Total Debt	4.2M	12.9M	15.3M	17.4M	8.1M	1.7M	0.0
Net Debt	-17.5M	-36.3M	-118.6M	-66.9M	-27.7M	-35.2M	-32.9M
Shares Outstanding	202,467,871	202,467,871	202,467,871	202,467,871	202,467,871	202,467,871	202,467,871

SEC Filings

QSI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 15, 2026	May 15, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 01, 2026	April 01, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 03, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 03, 2026	March 03, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 29, 2025	December 29, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 20, 2025	November 19, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 05, 2025	November 05, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 05, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 133 filings

Related Guides

Blog Categories

Continue your QSI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.